56 results
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
in the European Union and U.K. for reducing the risk of cisplatin-induced hearing loss in pediatric patients with localized, non-metastatic solid tumors
Fennec
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
certain member states of the European Union); provided that if the Euro ceases to exist then the currency adopted by the Netherlands shall replace Euro … , terrorist financing or the proceeds of criminal activity, including, without limitation, (i) the European Union Anti-Money Laundering Directives
424B7
FENC
Fennec Pharmaceuticals Inc
15 Mar 24
Prospectus with selling stockholder info
3:53pm
, PEDMARK® (known as PEDMARQSI® in the European Union);
the benefits of the use of PEDMARK®;
our ability to successfully commercialize PEDMARK®;
the rate … as PEDMARK® in the U.S.). Further, the decision included the receipt of a Pediatric Use Marketing Authorization (“PUMA”) in the European Union (“EU
8-K
EX-99.1
cnm26oqla64kz
6 Jun 23
Other Events
5:39pm
8-K
EX-99.1
m1x6 7qeweh
4 Apr 23
Other Events
12:32pm
8-K
EX-10.1
burqwf3yf1gur0 guf
1 Aug 22
Fennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor
4:15pm